QUOTE AND NEWS
Benzinga  Aug 12  Comment 
Ceres Inc (NASDAQ: CERE) shares climbed 293.66 percent to $3.75 as the company reported that it has been awarded a patent for its iCODE trait development system. Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares rose 33.22 percent to $3.12...
TheStreet.com  Aug 12  Comment 
NEW YORK (TheStreet) -- Shares of Ceres were jumping 293.17% to $3.75 on heavy trading volume after the agricultural biotechnology company received a patent for its iCODE multi-gene trait development system. The iCODE development system was...
Forbes  Aug 2  Comment 
This week’s Around The Universe features stories about Saturn's moon Tethys, the dwarf planet Ceres, Comet 67/P, a new rocky exoplanet, and more.
Forbes  Jul 18  Comment 
This week in space saw a successful satellite launch, a storm chase from space, new images of Ceres and Saturn, Jupiter's twin planet, images of the Quintuplet Cluster, and of course, New Horizons flying by Pluto!
Biomass Magazine  Jul 14  Comment 
Ceres Inc. has released financial results for its fiscal third quarter, reporting the company is continuing to realign its focus towards food and forage opportunities and biotechnology traits, rather than bioenergy markets.
SeekingAlpha  Jul 10  Comment 
Forbes  Jun 23  Comment 
NASA captured the image of a mysterious mountain on the surface of the dwarf planet Ceres.
Benzinga  Jun 19  Comment 
Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, today announced the continued realignment of its business to focus on food and forage opportunities and biotechnology traits for sugarcane and other crops. As part of the...
Forbes  Jun 8  Comment 
Dawn began its nearest orbit of Ceres in the past few days, and has begun to send back the closest images we're likely to see of the odd object any time soon.




 

Ceres (NASDAQ:CERE) is a biotechnology company which focuses on agriculture. Ceres sells seeds used to grow plants dedicated for use as biofuel. The seeds Ceres makes are bred to have low inputs, are weather hardy, and can grow at large scales. These dedicated plants compete with corn and sugarcane which are often used as fuelstock.[1]


Business Overview

For the full year ended in August 2011, Ceres reported a total revenue of $6.6M. During the period, the company reported a net loss of $36.3M. This compares with $6.6M in revenue in 2010 and a net loss of $22.6M. The majority of the revenue was from collaborative research and government grants while the largest cost was from research and development. [2]

New Updates

The company's initial public offering of stock on the NASDAQ occurred on February 21, 2012. The company offered 5M shares each for $13. This was below the $16-$17 revised price range. The company was originally planning to price between $21-$23. The deal raised a total of $65M. The lead mangers of the deal were Goldman Sachs Group (GS) and Barclays.[3]

Trends & Forces

Dependence on Government Grants

Historically, much of Ceres' revenue has been from government grants. This is part of the US government's goal to encourage the growth in biofuels. If these subsidies are removed, then Ceres will be impacted. This could happen if alternate forms of energy are discovered or if demand for a decrease in overall government spending rises. [4]


  1. CERE S-1/A 2012 PROSPECTUS SUMMARY "Our Company" pg 1
  2. CERE S-1/A 2012 PROSPECTUS SUMMARY "SUMMARY CONSOLIDATED FINANCIAL DATA" pg 10
  3. Renaissance Capital - IPO Home "Ceres prices IPO at $13, below revised range; insiders expected to have purchased 20% of the deal" 22 Feb 2012
  4. CERE S-1/A 2012 PROSPECTUS SUMMARY "RISK FACTORS" pg 13-21
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki